BRAF (V600E) mutation in isthmic malignant thyroid nodules

被引：3
|
作者：
Campenni, A. [1 ]
Giovanella, L. [2 ,3 ]
Alibrandi, A. [4 ]
Siracusa, M. [1 ]
Ruggeri, R. M. [5 ]
Baldari, S. [1 ]
机构：
[1] Univ Messina, Nucl Med Unit, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy
[2] Oncol Inst So Switzerland, Nucl Med, Bellinzona, Switzerland
[3] Oncol Inst So Switzerland, PET CT Ctr, Bellinzona, Switzerland
[4] Univ Messina, Dept Econ Business & Environm Sci & Quantitat Met, Messina, Italy
[5] Univ Messina, Dept Clin & Expt Med & Pharmacol, Endocrinol Sect, Messina, Italy
来源：
CLINICAL ENDOCRINOLOGY | 2016年 / 84卷 / 01期
关键词：
RISK; ABLATION; CANCER;
D O I：
10.1111/cen.12858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [31] Histiocytic sarcoma arising from thyroid gland with BRAF V600E mutation
    Ge, Rong
    Chang, Yuqing
    Gan, Yongli
    Zhu, Haidong
    Liu, Chuangfeng
    PATHOLOGY, 2020, 52 (05) : 603 - 605
  • [32] BRAF V600E Mutation in Malignant Melanoma-A Romanian Research Experience
    Avadanei, Elena-Roxana
    Caruntu, Irina-Draga
    Nuca, Irina
    Balan, Raluca
    Lozneanu, Ludmila
    Giusca, Simona-Eliza
    Amalinei, Cornelia
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [33] Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules
    Beisa, Augustas
    Kvietkauskas, Mindaugas
    Beisa, Virgilijus
    Stoskus, Mindaugas
    Ostaneviciute, Elvyra
    Jasiunas, Eugenijus
    Griskevicius, Laimonas
    Seinin, Dmitrij
    Sileikyte, Aukse
    Strupas, Kestutis
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2019, 127 (04) : 247 - 254
  • [34] Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
    Xing, Mingzhao
    Alzahrani, Ali S.
    Carson, Kathryn A.
    Shong, Young Kee
    Kim, Tae Yong
    Viola, David
    Elisei, Rossella
    Bendlova, Bela
    Yip, Linwah
    Mian, Caterina
    Vianello, Federica
    Tuttle, R. Michael
    Robenshtok, Eyal
    Fagin, James A.
    Puxeddu, Efisio
    Fugazzola, Laura
    Czarniecka, Agnieszka
    Jarzab, Barbara
    O'Neill, Christine J.
    Sywak, Mark S.
    Lam, Alfred K.
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    Nakayama, Hirotaka
    Clifton-Bligh, Roderick
    Tallini, Giovanni
    Holt, Elizabeth H.
    Sykorova, Vlasta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 42 - U79
  • [35] Investigation of V600E BRAF mutation in papillary thyroid carcinoma in the Polish population
    Brzezianska, Ewa
    Pastuszak-Lewandoska, Dorota
    Wojciechowska, Katarzyna
    Migdalska-Sek, Monika
    Cyniak-Magierska, Anna
    Nawrot, Ewa
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2007, 28 (04) : 351 - 359
  • [36] BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence
    Czarniecka, Agnieszka
    Oczko-Wojciechowska, Malgorzata
    Barczynski, Marcin
    GLAND SURGERY, 2016, 5 (05) : 495 - 505
  • [37] Lack of MAPK activation in papillary thyroid carcinoma with BRAF V600E mutation
    Zuo, Hui
    Nakamura, Yasushi
    Yasuoka, Hironao
    Nakamura, Misa
    Mori, Ichiro
    Miyauchi, Akira
    Kakudo, Kennichi
    CANCER RESEARCH, 2006, 66 (08)
  • [38] Immunohistochemical detection of BRAF V600E mutation status in anaplastic thyroid carcinoma
    Rushton, Sarah
    Burghel, George
    Wallace, Andrew
    Nonaka, Daisuke
    HISTOPATHOLOGY, 2016, 69 (03) : 524 - 526
  • [39] BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules
    Sheng, Danli
    Yu, Xiaoli
    Li, Hui
    Zhang, Murui
    Chen, Jianzhong
    MEDICINE, 2021, 100 (37)
  • [40] Evaluation of TERT Promoter and BRAF (V600E) Mutation Analysis on LBC-processed Thyroid Malignant Lesions
    Dell'Aquila, Marco
    Martini, Maurizio
    Fiorentino, Vincenzo
    Musarra, Teresa
    Zhang, Qianqian
    Brunelli, Chiara
    Fadda, Guido
    Larocca, Luigi Maria
    Rossi, Esther
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 341 - 341
12345